Biosafety in the clinical mycobacteriology laboratory.
This article presents an expanded agent summary statement for laboratorians working with Mycobacterium tuberculosis. It focuses on reducing the serious risk of infection in clinical laboratories that process specimens from tuberculosis patients or that work with purified cultures of tubercle bacilli. Administrative and engineering controls, practices and procedures, and personal protective equipment are discussed. Guidelines for packaging specimens for transfer to another laboratory also are presented.
Richmond
J Y
JY
Office of Health and Safety, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Knudsen
R C
RC
Good
R C
RC
D001432:Bacteriology / Q000592:standards*; D003264:Containment of Biohazards; D006801:Humans; D007753:Laboratories / Q000592:standards*; D017744:Medical Waste Disposal; D009164:Mycobacterium Infections / Q000517:prevention & control*; D009169:Mycobacterium tuberculosis; D011482:Protective Devices; D012307:Risk Factors; D012449:Safety; D014397:Tuberculosis, Pulmonary / Q000517:prevention & control*
D017744:Medical Waste Disposal